UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:January 17,
Boundless Bio (NASDAQ:BOLD)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas Boundless Bio.
Boundless Bio (NASDAQ:BOLD)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas Boundless Bio.

Noticias sobre Audentes Therapeutics, Inc. BOLD

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Lunes 13 de Mayo 2024 (1 semana hace) • Edgar (US Regulatory)
Form 8-K - Current report
Lunes 13 de Mayo 2024 (1 semana hace) • Edgar (US Regulatory)
Boundless Bio Reports First Quarter 2024 Financial Results and Corporate Highlights
Lunes 13 de Mayo 2024 (1 semana hace) • Business Wire
Boundless Bio to Present at the Citizens JMP Life Sciences Conference 2024
Lunes 6 de Mayo 2024 (2 semanas hace) • Business Wire
Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications
Jueves 11 de Abril 2024 (1 mes hace) • Business Wire
Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024
Lunes 8 de Abril 2024 (1 mes hace) • Business Wire

Más de Audentes Therapeutics, Inc. Artículos de Noticias